#BioHive-2
This is super interesting and should added in the AI supercomputer BioHive-2 of #Recursion Pharmaceuticals
nature.com Nature @nature.com · Oct 10
“This is probably the coolest experiment in organic chemistry,” said Peter Somfai, a member of the Nobel Committee for Chemistry, speaking at Wednesday's announcement

go.nature.com/4dphzFq
Chemistry Nobel for solving mystery of how ‘handed’ organic molecules can emerge
Nature - Prize awarded to two chemists who probed why life favours one mirror-image molecule over another.
go.nature.com
October 10, 2026 at 4:08 PM
Time for #Recursion Pharmaceuticals #$RXRX to increase security on his datacenter #BioHive-2, one of the most powerful supercomputers in #pharma.
September 13, 2026 at 8:13 PM
Das "KI-Update" liefert werktäglich eine Zusammenfassung der wichtigsten KI-Entwicklungen. #KI update
KI-Update kompakt: Google I/O, ChatGPT-Desktop-App, BioHive-2, Hippocampus
Das "KI-Update" liefert werktäglich eine Zusammenfassung der wichtigsten KI-Entwicklungen.
www.heise.de
May 15, 2024 at 1:03 PM
A new feature from @erikafry.bsky.social in @fortune.com opens with a striking image: For three weeks last May, employees from Nvidia and Recursion slept on the floor of a data center in Salt Lake City during a sprint to build the pharma industry’s most powerful supercomputer – BioHive-2. 🧵
April 3, 2025 at 3:01 PM
#RXRX MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy

https://www.stocktitan.net/news/RXRX/mit-and-recursion-release-boltz-2-next-generation-ai-model-to-sch64g5psf8n.html
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
MIT and Recursion (RXRX) have jointly developed and released Boltz-2, a groundbreaking open-source AI model for drug discovery. This biomolecular foundation model can predict both molecular structure and binding affinity simultaneously, approaching the accuracy of industry-standard free energy perturbation (FEP) calculations but at speeds up to 1000x faster. Trained on Recursion's NVIDIA supercomputer BioHive-2, Boltz-2 demonstrates superior performance in the CASP16 affinity challenge and utilizes approximately 5 million binding affinity assay measurements. The model features improved affinity prediction, advanced joint modeling capabilities, and enhanced physical plausibility through Boltz-steering. Released under an MIT license for both academic and commercial use, Boltz-2 represents a significant advancement in making large-scale virtual screening more practical and cost-effective for drug development.
www.stocktitan.net
June 6, 2025 at 2:00 PM
The development of this #opensource #model for academic and commercial use was a collaborative effort, combining #MIT’s deep academic expertise with #Recursion's #RXRX #AI research and #NVIDIA-accelerated #supercomputer, #BioHive-2
June 6, 2025 at 4:40 PM
#RXRX #RecursionPharmaceuticals

Will #AI ever cure #cancer?

The multibillion-dollar race to bring the first #AI-discovered #drug to market

fortune.com/2025/04/03/r...
April 11, 2025 at 8:08 AM
#RXRX #RECURSION

A partnership with #NVIDIA allowed the company to upgrade its “tech stack” with an on-premise #supercomputer called #BioHive-2, which ranked number 35 in the world in 2024 and is believed to be fastest #computer in the #biopharmaceutical space.

finance.yahoo.com/quote/RXRX/
Recursion Pharmaceuticals, Inc. (RXRX) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
finance.yahoo.com
March 26, 2025 at 9:47 AM